XML 13 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Operating expenses:        
Research and development $ 14,969,743 $ 6,962,907 $ 21,153,251 $ 18,198,767
General and administrative 3,038,064 3,379,750 6,248,420 8,947,167
Loss from operations (18,007,807) (10,342,657) (27,401,671) (27,145,934)
Other income (expense):        
Interest income 1,637,836 1,882,800 3,448,105 3,561,685
Interest expense (477,601) (527,141) (976,128) (1,018,428)
Total other income, net 1,160,235 1,355,659 2,471,977 2,543,257
Net loss $ (16,847,572) $ (8,986,998) $ (24,929,694) $ (24,602,677)
Net loss per share - basic $ (0.28) $ (0.15) $ (0.42) $ (0.42)
Net loss per share - diluted $ (0.28) $ (0.15) $ (0.42) $ (0.42)
Weighted average common shares outstanding - basic 59,414,489 58,791,920 59,414,489 58,791,762
Weighted average common shares outstanding - diluted 59,414,489 58,791,920 59,414,489 58,791,762